Clinical Trial Update: Efficacy Study of Substitution of Darunavir/Ritonavir (DRV/r) for Dual-boosted Protease Inhibitors [Phase 4]

View source ↗

Summary

Phase 4 efficacy study assessing substitution of darunavir/ritonavir for other boosted protease inhibitor regimens in HIV infection. Results were posted in 2010…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Darunavir (darunavir)
• Ritonavir (Ritonavir)

Snippet

Sponsor: Community Research Initiative of New England | Conditions: HIV Infections | Phase 4 | Status: COMPLETED | Results posted: 2010-08-17